SCHEMBL20150757

SCHEMBL20150757

CCc1nn(C(c2ccc(C(F)(F)F)c(F)c2)C2(C)CC2)c(N)c1C(N)=O

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 18/20 0.55
BTK Q06187 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18290691 0.92 PDE2A (0.61) PDE2ABTK
SCHEMBL18290695 0.87 PDE2A (0.58) PDE2ABTK
SCHEMBL20138414 0.86 PDE2A (0.77) PDE2ABTK
SCHEMBL20150755 0.85 PDE2A (0.51) PDE2ABTK
SCHEMBL20150742 0.84 PDE2A (0.72) PDE2A
SCHEMBL20150759 0.83 PDE2A (0.57) PDE2A
SCHEMBL20202570 0.81 PDE2A (0.49) PDE2A
SCHEMBL22475510 0.78 PDE2A (0.62) PDE2A
SCHEMBL18290688 0.77 PDE2A (0.57) PDE2ABTK
SCHEMBL18285738 0.77 PDE2A (0.72) PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134712-A1 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134712-A1 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS PDE12, PDE2A, PDE4D PDE2A 2/4885BTK 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.